Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
| Website | http://www.mesentech.com |
| Revenue | $5 million |
| Employees | 9 (4 on RocketReach) |
| Founded | 2018 |
| Address | 2222 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, CA |
| Phone | +1 317-272-3600 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical, Therapeutics |
| Competitors | Twilio, RingCentral, Vonage, Infobip, Sinch, Telesign, Telnyx, ZENVIA, Plivo, ClickSend +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Mesentech employee's phone or email?
The Mesentech annual revenue was $5 million in 2026.
Gang Chen is the Director of Medicinal Chemistry of Mesentech.
4 people are employed at Mesentech.
Mesentech is based in Vancouver, British Columbia.
The NAICS codes for Mesentech are [3254, 32541, 32, 325].
The SIC codes for Mesentech are [28, 283].